← FDA Drug Approvals (Drugs@FDA)

RAMELTEON

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ADAPTIS · Approved 2026-06-04

Drug application

FDA Application #

ANDA215485

Application type

Abbreviated New Drug Application (Generic)

Brand name

RAMELTEON

Generic name

Ramelteon

Active ingredients

RAMELTEON

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

ADAPTIS

First approval

2026-06-04

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown